Subscribe To
Nexpoint diversified reit: hunting for value with their preferreds
NexPoint Diversified Real Estate is trading at a 70% discount to its NAV, possibly raising doubts about...
October 16, 2023, 11:29 am
Netflix: a lot of value is in the cards
Netflix has seen a remarkable 109% surge since its 2022 lows, driven by factors such as the resolution of subs...
October 16, 2023, 11:20 am
Why martin marietta (mlm) is a top value stock for the long-term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style ...
October 16, 2023, 11:18 am
Why rpm international (rpm) is a top value stock for the long-term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style ...
October 16, 2023, 11:18 am
Are consumer discretionary stocks lagging american woodmark (amwd) this year?
Here is how American Woodmark (AMWD) and K12 (LRN) have performed compared to their sector so far this year....
October 16, 2023, 11:18 am
Is airsculpt technologies (airs) stock outpacing its business services peers this year?
Here is how Airsculpt Technologies, Inc. (AIRS) and SPX Technologies (SPXC) have performed compared to ...
October 16, 2023, 11:18 am
Should value investors buy ageas (agesy) stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Should value investors buy guess (ges) stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Are investors undervaluing the gap (gps) right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Is crestwood equity partners (ceqp) stock undervalued right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Is devon energy (dvn) stock undervalued right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Should value investors buy comp en de mn cemig (cig) stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
Should value investors buy peabody energy (btu) stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 16, 2023, 11:18 am
: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenon...
October 16, 2023, 11:11 am
Clearside biomedical positive oasis and extension study data presented at the retina society 56th annual scientific meeting
– Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – – ODYSSEY Phase 2b Clinical Trial E...
October 16, 2023, 11:05 am
Nasdaq composite technical analysis - will this support hold?
Last Friday, the market sold off as the University of Michigan Consumer Sentiment report saw a big miss across the board with the inflation expectatio...
October 16, 2023, 11:04 am
Olema oncology announces phase 2 monotherapy clinical results to be presented at the 2023 esmo congress
Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor ...
October 16, 2023, 11:02 am
Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc
Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of N...
October 16, 2023, 11:00 am
Enovis to host third quarter 2023 results conference call on november 7th
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today ...
October 16, 2023, 11:00 am
Modifi bio raises additional $4.3 million in seed funding
Financing will drive the further development of a new class of drugs targeting DNA repair defects in cancer. NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NE...
October 16, 2023, 11:00 am